R&D
Integrate or isolate: Incorporating traditional safety-relat...
Should traditional safety considerations be treated as distinct from broader ESG frameworks, or fully integrated within them?
Sales & Marketing
What does FDA's proposed DTC advertising rule mean for pharm...
Last month, the FDA quietly added a proposed rule to the 2026 Unified Agenda that – if finalised – could make prescription drug advertising untenable.
R&D
A practical route through regulatory uncertainty in clinical...
Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.
Patients
Sponsored
12 Questions with Kim Innes
Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
